Registered Trials
NCT04677660
Phase 1/2Japan
Total Enrollment: 200
Official Trial Registration:
This site is no longer being updated. Data are accurate as of 2 Dec 2022.
Vaccine Type: RNA
This vaccine is approved.
There are no trials for this phase.
This vaccine is the same formulation as the Moderna vaccine (mRNA-1273)
Japan
Total Enrollment: 200
© 2024 VIPER Group COVID19 Vaccine Tracker Team
Funding provided by the McGill University Interdisciplinary Initiative in Infection and Immunity (MI4)
This site is provided for informational purposes only based on publically available data.